Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular Carcinoma
Conclusions: Concurrent antibiotic use during immunotherapy was associated with higher mortality in patients with advanced HCC. Further studies should examine the role of gut dysbiosis on responses to ICI.Liver Cancer
Source: Liver Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Children | Cirrhosis | Hepatocellular Carcinoma | Immunotherapy | Laboratory Medicine | Liver | Liver Cancer | Liver Transplant | Study | Transplants | Urology & Nephrology | Yervoy